A study that defines the interactions between three immunity-regulating molecules — type 1 interferon, interleukin-1 and prostaglandin E2 — will help to explain the variable outcomes of tuberculosis infections. See Letter p.99
- Samuel M. Behar
- Christopher M. Sassetti